United States · FDA National Drug Code directory
Docusate Sodium and Sennosides
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62993-0002_48f5ab82-91b0-71fa-e063-6294a90a74c9
- Product NDC
- 62993-0002
- Form
- TABLET
- Composition / generic term
- Docusate Sodium and Sennosides
- Labeler
- Morepen Laboratories Limited
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20251001
- Source listing expiry
- 20271231
Source-listed ingredients
- DOCUSATE SODIUM — 50 mg/1
- SENNOSIDES — 8.6 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (62993-0002-1) · 62993-0002-1
- 60 TABLET in 1 BOTTLE (62993-0002-2) · 62993-0002-2
- 100 TABLET in 1 BOTTLE (62993-0002-3) · 62993-0002-3
- 1000 TABLET in 1 BOTTLE (62993-0002-4) · 62993-0002-4
- 3000 TABLET in 1 BOTTLE (62993-0002-5) · 62993-0002-5
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →